beta blocker: decrease heart rate

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents agent
Weight: 0.65
, high blood pressure
Weight: 0.63
, heart disease
Weight: 0.63
, vasodilator
Weight: 0.62
Siblings atenolol
Weight: 0.53
, lung cancer
Weight: 0.33
, cystic fibrosis
Weight: 0.33
, agonist
Weight: 0.32
, blood clot
Weight: 0.32

Related properties

Property Similarity
decrease heart rate 1.00
slow heart rate 0.89
affect rate 0.87
affect rate of respiration 0.83
increase risk 0.83
decrease blood pressure 0.81
increase end volume 0.80
affect heart 0.79
increase risk of diabetes 0.79
be in heart 0.78

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.31
Rule weight: 0.66
Evidence weight: 0.60
Similarity weight: 0.79
Evidence: 0.17
Plausible(high blood pressure, affect heart) ⋁
Evidence: 0.49
¬ Typical(beta blocker, decrease heart rate)
0.31
Rule weight: 0.66
Evidence weight: 0.58
Similarity weight: 0.79
Evidence: 0.14
Plausible(heart disease, affect heart) ⋁
Evidence: 0.49
¬ Typical(beta blocker, decrease heart rate)

Plausibility inheritance from parent to child

0.07
Rule weight: 0.09
Evidence weight: 0.93
Similarity weight: 0.79
Evidence: 0.52
Plausible(beta blocker, decrease heart rate) ⋁
Evidence: 0.14
¬ Plausible(heart disease, affect heart)
0.07
Rule weight: 0.09
Evidence weight: 0.92
Similarity weight: 0.79
Evidence: 0.52
Plausible(beta blocker, decrease heart rate) ⋁
Evidence: 0.17
¬ Plausible(high blood pressure, affect heart)

Remarkability exclusitivity betweem a parent and a child

0.11
Rule weight: 0.58
Evidence weight: 0.25
Similarity weight: 0.79
Evidence: 0.76
¬ Remarkable(beta blocker, decrease heart rate) ⋁
Evidence: 0.99
¬ Remarkable(high blood pressure, affect heart)
0.11
Rule weight: 0.58
Evidence weight: 0.24
Similarity weight: 0.79
Evidence: 0.76
¬ Remarkable(beta blocker, decrease heart rate) ⋁
Evidence: 0.99
¬ Remarkable(heart disease, affect heart)

Remarkability exclusitivity between siblings

0.06
Rule weight: 0.13
Evidence weight: 0.49
Similarity weight: 0.87
Evidence: 0.76
¬ Remarkable(beta blocker, decrease heart rate) ⋁
Evidence: 0.67
¬ Remarkable(lung cancer, affect rate)
0.03
Rule weight: 0.13
Evidence weight: 0.30
Similarity weight: 0.83
Evidence: 0.76
¬ Remarkable(beta blocker, decrease heart rate) ⋁
Evidence: 0.92
¬ Remarkable(lung cancer, affect rate of respiration)
0.03
Rule weight: 0.13
Evidence weight: 0.32
Similarity weight: 0.78
Evidence: 0.76
¬ Remarkable(beta blocker, decrease heart rate) ⋁
Evidence: 0.90
¬ Remarkable(blood clot, be in heart)

Remarkability from parent implausibility

0.30
Rule weight: 0.42
Evidence weight: 0.90
Similarity weight: 0.79
Evidence: 0.17
Plausible(high blood pressure, affect heart) ⋁
Evidence: 0.76
Remarkable(beta blocker, decrease heart rate) ⋁
Evidence: 0.52
¬ Plausible(beta blocker, decrease heart rate)
0.30
Rule weight: 0.42
Evidence weight: 0.89
Similarity weight: 0.79
Evidence: 0.14
Plausible(heart disease, affect heart) ⋁
Evidence: 0.76
Remarkable(beta blocker, decrease heart rate) ⋁
Evidence: 0.52
¬ Plausible(beta blocker, decrease heart rate)

Remarkability from sibling implausibility

0.49
Rule weight: 0.60
Evidence weight: 0.99
Similarity weight: 0.83
Evidence: 0.52
Plausible(beta blocker, decrease heart rate) ⋁
Evidence: 0.92
Remarkable(lung cancer, affect rate of respiration) ⋁
Evidence: 0.37
¬ Plausible(lung cancer, affect rate of respiration)
0.47
Rule weight: 0.60
Evidence weight: 0.91
Similarity weight: 0.87
Evidence: 0.52
Plausible(beta blocker, decrease heart rate) ⋁
Evidence: 0.67
Remarkable(lung cancer, affect rate) ⋁
Evidence: 0.59
¬ Plausible(lung cancer, affect rate)
0.46
Rule weight: 0.60
Evidence weight: 0.99
Similarity weight: 0.78
Evidence: 0.52
Plausible(beta blocker, decrease heart rate) ⋁
Evidence: 0.90
Remarkable(blood clot, be in heart) ⋁
Evidence: 0.27
¬ Plausible(blood clot, be in heart)

Salient implies Plausible

0.19
Rule weight: 0.28
Evidence weight: 0.68
Similarity weight: 1.00
Evidence: 0.52
Plausible(beta blocker, decrease heart rate) ⋁
Evidence: 0.66
¬ Salient(beta blocker, decrease heart rate)

Similarity expansion

0.62
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.89
Evidence: 0.76
Remarkable(beta blocker, decrease heart rate) ⋁
Evidence: 0.77
¬ Remarkable(beta blocker, slow heart rate)
0.56
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.81
Evidence: 0.76
Remarkable(beta blocker, decrease heart rate) ⋁
Evidence: 0.79
¬ Remarkable(beta blocker, decrease blood pressure)
0.55
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.79
Evidence: 0.76
Remarkable(beta blocker, decrease heart rate) ⋁
Evidence: 0.73
¬ Remarkable(beta blocker, increase risk of diabetes)
0.54
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.81
Evidence: 0.66
Salient(beta blocker, decrease heart rate) ⋁
Evidence: 0.65
¬ Salient(beta blocker, decrease blood pressure)
0.54
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.81
Evidence: 0.49
Typical(beta blocker, decrease heart rate) ⋁
Evidence: 0.43
¬ Typical(beta blocker, decrease blood pressure)
...

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.88
Similarity weight: 1.00
Evidence: 0.66
Salient(beta blocker, decrease heart rate) ⋁
Evidence: 0.49
¬ Typical(beta blocker, decrease heart rate) ⋁
Evidence: 0.76
¬ Remarkable(beta blocker, decrease heart rate)

Typical implies Plausible

0.37
Rule weight: 0.48
Evidence weight: 0.77
Similarity weight: 1.00
Evidence: 0.52
Plausible(beta blocker, decrease heart rate) ⋁
Evidence: 0.49
¬ Typical(beta blocker, decrease heart rate)

Typicality and Rermarkability incompatibility between a parent and a child

0.40
Rule weight: 0.51
Evidence weight: 1.00
Similarity weight: 0.79
Evidence: 0.76
¬ Remarkable(beta blocker, decrease heart rate) ⋁
Evidence: 0.00
¬ Typical(heart disease, affect heart)
0.40
Rule weight: 0.51
Evidence weight: 0.99
Similarity weight: 0.79
Evidence: 0.76
¬ Remarkable(beta blocker, decrease heart rate) ⋁
Evidence: 0.01
¬ Typical(high blood pressure, affect heart)

Typicality and Rermarkability incompatibility between siblings

0.10
Rule weight: 0.14
Evidence weight: 0.93
Similarity weight: 0.78
Evidence: 0.76
¬ Remarkable(beta blocker, decrease heart rate) ⋁
Evidence: 0.09
¬ Typical(blood clot, be in heart)
0.10
Rule weight: 0.14
Evidence weight: 0.87
Similarity weight: 0.83
Evidence: 0.76
¬ Remarkable(beta blocker, decrease heart rate) ⋁
Evidence: 0.18
¬ Typical(lung cancer, affect rate of respiration)
0.06
Rule weight: 0.14
Evidence weight: 0.54
Similarity weight: 0.87
Evidence: 0.76
¬ Remarkable(beta blocker, decrease heart rate) ⋁
Evidence: 0.61
¬ Typical(lung cancer, affect rate)

Typicality inheritance from parent to child

0.38
Rule weight: 0.48
Evidence weight: 1.00
Similarity weight: 0.79
Evidence: 0.49
Typical(beta blocker, decrease heart rate) ⋁
Evidence: 0.00
¬ Typical(heart disease, affect heart)
0.38
Rule weight: 0.48
Evidence weight: 1.00
Similarity weight: 0.79
Evidence: 0.49
Typical(beta blocker, decrease heart rate) ⋁
Evidence: 0.01
¬ Typical(high blood pressure, affect heart)